LANSING, Mich. (WLNS) – Sparrow Hospital is highlighting a special cancer program early Monday morning.
Many people are benefiting from the ground-breaking clinical trial that uses genetic test results to match patients with targeted drugs.
The trial was first organized by the American Society of Clinical Oncology and was first tried in Michigan and a few other states.
It has since expanded to 15 states.
Sparrow says that it is one of the most successful parties at registering patients for the trial.